Delivra Health Brands Inc.
DHBUF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 8% | 26.4% | 20.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 50.7% | 51.7% | 49.3% | 32% |
| EBITDA | $0 | $0 | $0 | -$0 |
| % Margin | 1.1% | 19% | 14.3% | -52.3% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -6.5% | 7.1% | -1.9% | -86.1% |
| EPS Diluted | -0.028 | 0.031 | -0.007 | -0.28 |
| % Growth | -191.2% | 520.5% | 97.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |